This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Neuromyotonia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • neuromyotonia (Isaacs syndrome) is a disorder of peripheral nerve hyperexcitability characterized by myokymia, muscle cramps and stiffness, delayed muscle relaxation after contraction (pseudomyotonia), and hyperhidrosis, associated with well described spontaneous electromyographic features
    • usually neuromyotonia is an acquired disorder associated with autoantibodies against neuronal voltage-gated potassium channels
    • familial neuromyotonia occurs very rarely
      • mutations of KCNA1, encoding the K+ channel subunit hKv1.1, have been reported in rare families with neuromyotonia
    • clinical features are diverse and include cramps, generalized muscle twitching, stiffness, and pseudomyotonia
      • some patients experience paresthesias or hyperhidrosis that may be secondary to muscle overactivity
    • underlying electrophysiologic basis of Isaacs’ syndrome is the spontaneous repetitive burst of single motor-unit potentials, with high intraburst frequency
      • most common electromyographic abnormalities are myokymic and neuromyotonic discharges
        • both terms are used to describe this spontaneous electrical activity, and both forms of discharge are sometimes seen in the same patient
          • main difference between them arises from the higher frequencies (150-300 Hz) and waning features of neuromyotonic discharges
    • distinction between neuromyotonia and other entities, such as cramp-fasciculation syndrome and stiff-man syndrome, lies in the electromyographic and clinical findings
      • rippling-muscle disease is a rare autosomal-dominant disorder (characterized by mechanically induced, involuntary muscle contractions) which should always be included in the differential diagnosis of Isaacs’ syndrome
    • in addition to conventional pharmacotherapy with anticonvulsants such as phenytoin or carbamazepine, immunomodulatory treatments using high doses of intravenous immunoglobulin and plasmapheresis have also been employed (3)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.